Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry

Recruiting now

Conditions studied: Autoimmune Diseases, Autoinflammatory Diseases

In brief

An observational, multi-center, longitudinal registry study for Chinese pediatric patients with rheumatic and immunologic diseases.

Key facts

Study ID

NCT06417502

Run by

Peking Union Medical College Hospital

People needed

20000

Starts

2022-04-29

Expected to finish

2031-12-31

Last updated by the study team

2024-05-16

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age <= 18 years old
• Diagnosed with rheumatic and immunologic diseases (including diffuse connective tissue diseases, arthritis, vasculitis, inborn errors of immunity)
• Diagnosed and Treated in China

You may not qualify if…

• Disagreement of involving in this study by the patient or his/her family.

Where it is running

• Peking Union Medical College Hospital — Beijing, Beijing Municipality, China (enrolling)
• Beijing Children's Hospital, Capital Medical University — Beijing, Beijing Municipality, China (enrolling)
• Third Hospital of Peking University — Beijing, Beijing Municipality, China (enrolling)
• Chidren's Hospital of Chongqing Medical University — Chongqing, Chongqing Municipality, China (enrolling)
• Shenzhen Children's Hospital — Shenzhen, Guangdong, China (enrolling)
• The University of Hong Kong Shenzhen Institute of Research and Innovation (HKU-SIRI) — Shenzhen, Guangdong, China (enrolling)
• The Second Xiangya Hospital of Central South University — Changsha, Hunan, China (enrolling)
• Children's Hospital of Nanjing Medical University — Nanjing, Jiangsu, China (enrolling)
• Children's Hospital of Zhejiang University School of Medicine — Hangzhou, Zhejiang, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.